A clinically validated shatavari extract is redefining how botanical ingredients support women through perimenopause and menopause. Recent findings published in Functional Foods in Health and Disease highlight that Xeya Modern Shatavari, standardized to 15% bioactive shatavarins, significantly alleviated vasomotor, psychological, and menstrual symptoms at low daily doses of just 50–100 mg. In a 120-day, placebo-controlled clinical study involving early perimenopausal women, supplementation led to marked improvements in hot flashes, fatigue, sleep quality, mood swings, anxiety, and brain fog, as reflected by substantial reductions in Menopause Rating Scale scores. Beyond symptom relief, the extract demonstrated hormone-modulating effects, improving key reproductive markers such as FSH, LH, AMH, and estradiol, while also increasing ovarian follicle count.By integrating patient-reported outcomes, physician assessments, biomarkers, and physical measures, the study offers one of the most comprehensive clinical evaluations of shatavari to date. These results position shatavari as a credible, multi-targeted botanical—poised to emerge as a cornerstone ingredient in next-generation women’s health supplements.
Source : https://www.ffhdj.com/index.php/ffhd/article/view/1684
